AGY THERAPEUTICS
AGY Therapeutics has one focus: the discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system AGY has a pipeline of novel CNS therapeutic programs in the clinic and in preclinical development to meet major unmet medical needs. AGY built its pipeline using its unique, proprietary platform for functional gene discovery and mapping out specific pathways underlying central nervous system diseases. By harnessing these capabilities, AGY identified potential target proteins that can be modulated to block the progression of the disease process. This is paving the way for novel CNS therapeutics and future growth for AGY.
AGY THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Medical Therapeutics
Founded:
1998-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.agyinc.com
Total Employee:
51+
Status:
Active
Contact:
650-615-4530
Total Funding:
22 M USD
Technology used in webpage:
Peg Technic
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Investors List
JAFCO
JAFCO investment in Series C - AGY Therapeutics
Alta Partners
Alta Partners investment in Series C - AGY Therapeutics
Cheng Xin Technology Development Corp
Cheng Xin Technology Development Corp investment in Series C - AGY Therapeutics
Lotus
Lotus investment in Series C - AGY Therapeutics
GE Capital
GE Capital investment in Series C - AGY Therapeutics
HBM Partners
HBM Partners investment in Series C - AGY Therapeutics
Gimv
Gimv investment in Series C - AGY Therapeutics
Bear Stearns Health Innoventures L.P
Bear Stearns Health Innoventures L.P investment in Series C - AGY Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - AGY Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - AGY Therapeutics
